Skip to content

Does Prehabilitation Improve Outcome in Coloncancer Surgery?

The Effect of Prehabilitation on Surgical Complications Following Colon Surgery - a Prospective Randomized Study

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04199208
Acronym
PRIO
Enrollment
160
Registered
2019-12-13
Start date
2020-10-01
Completion date
2028-01-07
Last updated
2020-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery--Complications

Keywords

exercise therapy, perioperative period, coloncancer

Brief summary

The study aims to find out if complications after surgery for large bowel (colon) cancer can be reduced or avoided in the most frail and elderly by letting them go through an exercise- and diet regime prior to the surgical procedure.

Detailed description

All patients with colon cancer who are intended for curative surgery without neoadjuvant chemotherapy who are \>=60 years old will be screened with an ergospirometry. The ones that have a ventilate anaerobic threshold (VAT) of less than 11 mg/ml/kg will be included in the study as they are considered extra frail and have a previously proven high risk for complications. These patients will be randomized to standard care or an intervention of prehabilitation consisting of immunonutrition (protein supplement, multivitamin supplement, Selene etc) and an exercise regimen with 4x1 hours per week of cycling on an ergometer. The exercise regimen will be performed in a group of patients and will be led by a physical therapist to ensure compliance. The resistance of the ergometer will be standardized according to the patient's VAT. The primary outcome measures will be number of and severity of postoperative complications. Secondary outcome measures include quality of life during prehabilitation with repeated measurements during 5 years after surgery, disease-free survival and overall survival.

Interventions

OTHERPrehabilitation and Immunonutrition

See study synopsis

Standard care as per the daily routines of the Hospital at which the study takes place

Sponsors

Region Skane
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

Randomized two-armed clinical trial

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 60 years of older * Colon cancer diagnosis (macroscopic, microscopic or x-ray diagnosed) * Ventilatory Anaerobic Threshold \<11mg/ml/kg * Planned open or laparoscopic colectomy due to colon cancer

Exclusion criteria

* Lower extremity amputee * Disease requiring radio- and/or chemotherapy prior to surgery/palliative disease * Distal metastases (Locoregional lymph nodes are OK)

Design outcomes

Primary

MeasureTime frameDescription
ComplicationsAssessed when patient is discharged from hospitalSeverity of postoperative complications according do Clavien-Dindo

Secondary

MeasureTime frameDescription
Quality of life with SF-36At point in time when patient is informed of the cancer, after prehabilitation (just before surgery), 30 days, 2, 3 and 6 months, 1, 3 and 5 years after surgery.Quality of life
Disease-free survival30 and 90 days after surgery, 1, 3 and 5 years after surgery.Cancer-free survival Cancer-free survival of the group of the group
Overall survival30 and 90 days after surgery, 1, 3 and 5 years after surgery.Overall survival of the group (taking all causes of death into account)

Contacts

Primary ContactStefan Öberg, MD, PhD
stefan.oberg@med.lu.se+46424061000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026